Intra-host diversity and evolution of hepatitis C virus endemic to Côte d'Ivoire

Journal of Medical Virology

Volumn 86, Issue 5, 2014, Pages 765-771

  Forbi, Joseph C ^a   Campo, David S ^a   Purdy, Michael A ^a   Dimitrova, Zoya E ^a   Skums, Pavel ^a   Xia, Guo liang ^a   Punkova, Lili T ^a   Ganova Raeva, Lilia M ^a   Vaughan, Gilberto ^a   Ben Ayed, Yousr ^a   Switzer, William M ^a   Khudyakov, Yury E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

C te d'Ivoire; Hepatitis C virus; Molecular epidemiology; West Africa

Indexed keywords

ARTICLE; CONTROLLED STUDY; COTE D'IVOIRE; ENDEMIC DISEASE; FEMALE; GENE SEQUENCE; GENETIC DISTANCE; GENETIC VARIABILITY; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 2; HUMAN; MAJOR CLINICAL STUDY; MICROBIAL DIVERSITY; MOLECULAR DYNAMICS; NEXT GENERATION SEQUENCING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PYROSEQUENCING; VIRUS ISOLATION;

HEPATITIS C VIRUS;

CÔTE D'IVOIRE; HEPATITIS C VIRUS; MOLECULAR EPIDEMIOLOGY; WEST AFRICA;

AFRICA; AFRICA, WESTERN; CLUSTER ANALYSIS; COTE D'IVOIRE; ENDEMIC DISEASES; EVOLUTION, MOLECULAR; FEMALE; GENETIC VARIATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84895926095     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23897     Document Type: Article

References (38)

1. Averhoff FM, Glass N, Holtzman D. 2012. Global burden of hepatitis C: Considerations for healthcare providers in the United States. Clin Infect Dis 55:S10-S15.
2. Bengue AKKM, Ekaza E, Siransy-Bogui L, N'Golo DC, Labonté P, Dosso M. 2008. Hepatitis C virus infection in Abidjan Cote d'Ivoire: Heterogeneity of genotypes. Sci Res Essay 3:139-142.
3. Candotti D, Temple J, Sarkodie F, Allain JP. 2003. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol 77:7914-7923.
4. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451-2455.
5. Combe P, La Ruche G, Bonard D, Ouassa T, Faye-Kette H, Sylla-Koko F, Dabis F, Group D-CS. 2001. Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Cote d'Ivoire, West Africa. Trans R Soc Trop Med Hyg 95:493-496.
6. Duffy S, Shackelton LA, Holmes EC. 2008. Rates of evolutionary change in viruses: Patterns and determinants. Nat Rev Genet 9:267-276.
7. EASL. 1999. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol 31:3-8.
8. Excoffier L, Laval G, Schneider S. 2005. Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 1:47-50.
9. Farci P. 2011. New insights into the HCV quasispecies and compartmentalization. Semin Liver Dis 31:356-374.
10. Forbi JC, Vaughan G, Purdy MA, Campo DS, Xia GL, Ganova-Raeva LM, Ramachandran S, Thai H, Khudyakov YE. 2010. Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria. PLoS ONE 5:e11615.
11. Forbi JC, Purdy MA, Campo DS, Vaughan G, Dimitrova ZE, Ganova-Raeva LM, Xia GL, Khudyakov YE. 2012. Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa. J Gen Virol 93:1410-1421.
12. Harnois DM. 2012. Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma. Mayo Clin Proc 87:7-8.
13. Itskowitz MS. 2007. Hepatitis C: Epidemiology, diagnosis, and management. Compr Ther 33:87-93.
14. Laurent C, Bourgeois A, Mpoudi M, Butel C, Mpoudi-Ngole E, Delaporte E. 2007. HIV and hepatitis C virus coinfection, Cameroon. Emerg Infect Dis 13:514-516.
15. Lindenbach BD, Rice CM. 2005. Unravelling hepatitis C virus replication from genome to function. Nature 436:933-938.
16. Madhava V, Burgess C, Drucker E. 2002. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2:293-302.
17. Markov PV, Pepin J, Frost E, Deslandes S, Labbe AC, Pybus OG. 2009. Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. J Gen Virol 90:2086-2096.
18. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. 2013. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology 57:1333-1342.
19. Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M. 2012. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int 32:339-345.
20. Nei M. 1987. Molecular evolutionary genetics. New York: Columbia University Press.
21. Njouom R, Pasquier C, Ayouba A, Sandres-Saune K, Mfoupouendoun J, Mony Lobe M, Tene G, Thonnon J, Izopet J, Nerrienet E. 2003. Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: Prevalence, viremia, and genotypes. J Med Virol 69:384-390.
22. Njouom R, Nerrienet E, Dubois M, Lachenal G, Rousset D, Vessiere A, Ayouba A, Pasquier C, Pouillot R. 2007. The hepatitis C virus epidemic in Cameroon: Genetic evidence for rapid transmission between 1920 and 1960. Infect Genet Evol 7:361-367.
23. Nkrumah B, Owusu M, Frempong HO, Averu P. 2011. Hepatitis B and C viral infections among blood donors from rural Ghana. Ghana Med J 45:97-100.
24. Okwen MP, Ngem BY, Alomba FA, Capo MV, Reid SR, Ewang EC. 2011. Uncovering high rates of unsafe injection equipment reuse in rural Cameroon: Validation of a survey instrument that probes for specific misconceptions. Harm Reduct J 8:4.
25. Pouillot R, Lachenal G, Pybus OG, Rousset D, Njouom R. 2008. Variable epidemic histories of hepatitis C virus genotype 2 infection in West Africa and Cameroon. Infect Genet Evol 8:676-681.
26. Prati D. 2006. Transmission of hepatitis C virus by blood transfusions and other medical procedures: A global review. J Hepatol 45:607-616.
27. Raghuraman S, Subramaniam T, Daniel D, Sridharan G, Abraham P. 2003. Occurrence of false positives during testing for antibodies to hepatitis C virus among volunteer blood donors in India. J Clin Microbiol 41:1788-1790.
28. Ramachandran S, Xia GL, Ganova-Raeva LM, Nainan OV, Khudyakov Y. 2008. End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: Performance under optimal and suboptimal conditions. J Virol Methods 151:217-224.
29. Ramachandran S, Campo DS, Dimitrova ZE, Xia GL, Purdy MA, Khudyakov YE. 2011. Temporal variations in the hepatitis C virus intrahost population during chronic infection. J Virol 85:6369-6380.
30. Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, Leroy V, Dabis F, Rouzioux C, Anrs D-B, Group CS. 2004. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: The ANRS 1236 study. J Med Virol 74:34-40.
31. Segbena AY, Prince-David M, Kagone TS, Dagnra AY. 2005. Human immunodeficiency virus, hepatitis C virus and hepatitis B viruses in patients with sickle-cell disease in Togo. Transfus Clin Biol 12:423-426.
32. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
33. Skums P, Dimitrova Z, Campo DS, Vaughan G, Rossi L, Forbi JC, Yokosawa J, Zelikovsky A, Khudyakov Y. 2012. Efficient error correction for next-generation sequencing of viral amplicons. BMC Bioinform 13:S6.
34. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P. 1997. The origin of hepatitis C virus genotypes. J Gen Virol 78:321-328.
35. Tamura K, Nei M, Kumar S. 2004. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci USA 101:11030-11035.
36. Torresi J, Johnson D, Wedemeyer H. 2011. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. J Hepatol 54:1273-1285.
37. Zeba MT, Sanou M, Bisseye C, Kiba A, Nagalo BM, Djigma FW, Compaore TR, Nebie YK, Kienou K, Sagna T, Pietra V, Moret R, Simpore J. 2012. Characterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina Faso. Blood Transfus 1-5.
38. Zhingoora-Books. 2012. Cote d'Ivoire. USA: CreateSpace Independent Publishing Platform.